fbpx

Barrett’s Esophagus- Conventional or Non-Conventional Therapy to Treat?

Share Button

Barrett’s Esophagus (BE) is not cancer. You can call BE cancer stage 0 or pre-cancer.┬áTreatment can be either conventional or non-conventional

According to the first article linked and excerpted below, the math is about 10% of GERD patients develop BE and about 1% of BE patients develop esophageal cancer.

Image result for photo of barrett's esophagus

While the risk of BE progressing to esophageal cancer is low, most people who are diagnosed with anything even close to cancer want that condition healed.

I am a cancer survivor myself and I understand the desire to reduce your risk of cancer, any cancer, as much as possible.

While radio-frequency ablation of BE is safe and effective according to the study below you can undergo several evidence-based, non-toxic therapies to reduce your risk of esophageal cancer.

The advantage of pursuing evidence-based, non-toxic BE therapies is that you will reduce your risk of esophageal as well as a host of other cancers including prostate, colon, breast cancer and others.

For more information about non-toxic, non-conventional therapies for to heal your BE, scroll down the page, post a comment or question and I will reply to you ASAP.

Thank you

David Emerson

  • Cancer survivor
  • Cancer Coach
  • Director ┬áPeopleBeatingCancer

Barrett’s Esophagus: Symptoms, Causes, and Treatments

“Barrett’s esophagus is a serious complication of GERD, which stands for gastroesophageal reflux disease. In Barrett’s esophagus, normal tissue lining the esophagus — the tube that carries food from the mouth to the stomach — changes to tissue that resembles the lining of the intestine. About 10% of people with chronic symptoms of GERD develop Barrett’s esophagus.

Less than 1% of people with Barrett’s esophagus develop this particular cancer (EC). Nevertheless, if you’ve been diagnosed with Barrett’s esophagus, it’s important to have routine examinations of your esophagus.”

When to consider endoscopic ablation therapy for Barrett’s esophagus.

Summary–┬áThe excellent efficacy, side-effect profile, and cost-effectiveness appear to make RFA the intervention of choice in cases of high-grade dysplasia. RFA for low-grade dysplasia may be of value in young patients and/or those with long segment or multifocal disease. Treatment of nondysplastic Barrett’s esophagus is of uncertain value. PDT appears to have a higher stricture rate and to be more expensive than RFA…”

Leave a Comment:

2 comments
Add Your Reply